HIV infection and osteoporosis
- PMID: 25709813
- PMCID: PMC4325555
- DOI: 10.1038/bonekey.2015.3
HIV infection and osteoporosis
Abstract
In the past two decades, the life expectancy of people living with HIV infection has increased significantly, and osteoporosis has emerged as a significant comorbidity. In addition to traditional risk factors for fracture, specific factors related to HIV infection are also likely to contribute, including antiretroviral therapy. The heterogeneity of the HIV-infected population in terms of age and ethnicity presents many challenges to the prevention and management of bone disease, and further studies are required to establish optimal approaches to risk assessment and treatment.
Conflict of interest statement
The author declares no conflict of interest.
References
-
- World Health Organization. HIV/AIDS. Available at: http://www.who.int/hiv/data/en/ (Accessed 23 November 2014).
-
- Carr A, Miller J, Eisman JA, Cooper DA. Osteopenia in HIV-infected men: association with asymptomatic lactic acidaemia and lower weight pre-antiretroviral therapy. AIDS 2001;15:703–709. - PubMed
-
- Knobel H, Guelar A, Vallecillo G, Nogués X, Díez A. Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS 2001;15:807–808. - PubMed
-
- Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J. Decreased bone mineral density in HIV infected patients is independent of retroviral therapy. AIDS 2003;17:1917–1923. - PubMed
-
- Teichmann J, Stephan E, Lange U, Discher T, Friese G, Lohmeyer J et al.. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. J Infect 2003;46:221–227. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous